Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

237 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
New anti-emetic treatments.
Roila F, Garassino M, Fatigoni S. Roila F, et al. Ann Oncol. 2007 Jul;18 Suppl 9:ix43-7. doi: 10.1093/annonc/mdm293. Ann Oncol. 2007. PMID: 17631595 Free article. Review. No abstract available.
New antiemetic drugs.
Roila F, Fatigoni S. Roila F, et al. Ann Oncol. 2006 Mar;17 Suppl 2:ii96-100. doi: 10.1093/annonc/mdj936. Ann Oncol. 2006. PMID: 16608997 Free article. Review.
Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study.
Roila F, Ruggeri B, Ballatori E, Fatigoni S, Caserta C, Licitra L, Mirabile A, Ionta MT, Massidda B, Cavanna L, Palladino MA, Tocci A, Fava S, Colantonio I, Angelelli L, Ciuffreda L, Fasola G, Zerilli F. Roila F, et al. Ann Oncol. 2015 Jun;26(6):1248-1253. doi: 10.1093/annonc/mdv132. Epub 2015 Mar 5. Ann Oncol. 2015. PMID: 25743855 Free article. Clinical Trial.
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin.
Bossi P, Cortinovis D, Fatigoni S, Cossu Rocca M, Fabi A, Seminara P, Ripamonti C, Alfieri S, Granata R, Bergamini C, Agustoni F, Bidoli P, Nolè F, Pessi MA, Macchi F, Michellini L, Montanaro F, Roila F. Bossi P, et al. Among authors: roila f. Ann Oncol. 2017 Oct 1;28(10):2547-2551. doi: 10.1093/annonc/mdx315. Ann Oncol. 2017. PMID: 28666335 Free article. Clinical Trial.
Reply to T.L. Ng et al and L. Celio et al.
Roila F, Fatigoni S, Ballatori E. Roila F, et al. J Clin Oncol. 2014 Jul 10;32(20):2187-8. doi: 10.1200/JCO.2014.55.8197. Epub 2014 Jun 9. J Clin Oncol. 2014. PMID: 24912894 No abstract available.
Fatigue, a major still underestimated issue.
Ripamonti CI, Antonuzzo A, Bossi P, Cavalieri S, Roila F, Fatigoni S. Ripamonti CI, et al. Among authors: roila f. Curr Opin Oncol. 2018 Jul;30(4):219-225. doi: 10.1097/CCO.0000000000000451. Curr Opin Oncol. 2018. PMID: 29877886 Review.
Cancer-related fatigue: ESMO Clinical Practice Guidelines for diagnosis and treatment.
Fabi A, Bhargava R, Fatigoni S, Guglielmo M, Horneber M, Roila F, Weis J, Jordan K, Ripamonti CI; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Fabi A, et al. Among authors: roila f. Ann Oncol. 2020 Jun;31(6):713-723. doi: 10.1016/j.annonc.2020.02.016. Epub 2020 Mar 12. Ann Oncol. 2020. PMID: 32173483 Free article. No abstract available.
237 results